O TRATAMENTO FARMACOLÓGICO DA HIPERTENSÃO ARTERIAL SISTÊMICA NA SAÚDE PÚBLICA BRASILEIRA NO SÉCULO XXI

Bárbara Stéphane de Macedo Guedes; Bárbara Stéphane de Macedo Guedes; Bárbara Stéphane de Macedo Guedes

doi:10.47094/978-65-88958-73-5/10-16

O TRATAMENTO FARMACOLÓGICO DA HIPERTENSÃO ARTERIAL SISTÊMICA NA SAÚDE PÚBLICA BRASILEIRA NO SÉCULO XXI

A Hipertensão Arterial Sistêmica (HAS) acomete cerca de 1,2 bilhão de adultos no mundo, segundo a OMS. De acordo com Ministério da Saúde, um a cada quatro adultos no país possui a doença. Ela tem grande importância por afetar grande parte da população mundial, por ser fator de risco para várias doenças possivelmente fatais e por ter um tratamento crônico para controle da doença. Diante disso, o serviço público tem papel fundamental em dar suporte ao cidadão melhorando sua qualidade de vida ao promover a saúde. Para tal finalidade, criou-se em 1971 a primeira política de medicamentos chamada Central de Medicamentos (CEME), seguida da Relação Nacional de Medicamentos Essenciais (RENAME) em 1975 que vigora até os dias atuais. Após a Constituição de 1988, o Sistema Único de Saúde (SUS), criado pela Lei 8080/1990, tornou-se o serviço público responsável por acolher o paciente no tratamento da HAS. O atendimento ao paciente inicia desde a atenção primária nas Unidades Básicas de Saúde (UBSs) até o atendimento em nível terciário como em hospitais. Além disso, o SUS fornece medicamentos gratuitamente nas UBSs e unidades farmacêuticas credenciadas ao programa Farmácia Popular. Dessa maneira, o paciente adere com maior facilidade ao tratamento da hipertensão e reduz os riscos de outras doenças fatais.

Descrição Autores Download Ler Online

O TRATAMENTO FARMACOLÓGICO DA HIPERTENSÃO ARTERIAL SISTÊMICA NA SAÚDE PÚBLICA BRASILEIRA NO SÉCULO XXI

Doi: 10.47094/978-65-88958-73-5/10-16

PALAVRAS CHAVE: hipertensão arterial sistêmica. anti-hipertensivo. Saúde Pública.

KEYWORDS: Systemic Arterial Hypertension (SAH) affects about 1.2 billion adults worldwide, according to the WHO. According to the Ministry of Health, one in every four adults in the country has the disease. It is of great importance for affecting a large part of the world population, for being a risk factor for several possibly fatal diseases and for having a chronic treatment to control the disease. Therefore, the public service has a fundamental role in supporting citizens, improving their quality of life by promoting health. For this purpose, the first medicine policy was created in 1971, called the Medicines Center (MC), followed by the National List of Essential Medicines (NLEM) in 1975, which is in force until the present day. After the 1988 Constitution, the Unified Health System (UHS), created by Law 8080/1990, became the public service responsible for receiving patients in the treatment of SAH. Patient care starts from primary care in Basic Health Units (BHU) to care at the tertiary level, such as in hospitals. In addition, UHS provides medicines free of charge at BHU and pharmaceutical units accredited to the Popular Pharmacy program. In this way, the patient more easily adheres to the treatment of hypertension and reduces the risk of other fatal diseases.

ABSTRACT:
Systemic Arterial Hypertension (SAH) affects about 1.2 billion adults worldwide, according to the WHO. According to the Ministry of Health, one in every four adults in the country has the disease. It is of great importance for affecting a large part of the world population, for being a risk factor for several possibly fatal diseases and for having a chronic treatment to control the disease. Therefore, the public service has a fundamental role in supporting citizens, improving their quality of life by promoting health. For this purpose, the first medicine policy was created in 1971, called the Medicines Center (MC), followed by the National List of Essential Medicines (NLEM) in 1975, which is in force until the present day. After the 1988 Constitution, the Unified Health System (UHS), created by Law 8080/1990, became the public service responsible for receiving patients in the treatment of SAH. Patient care starts from primary care in Basic Health Units (BHU) to care at the tertiary level, such as in hospitals. In addition, UHS provides medicines free of charge at BHU and pharmaceutical units accredited to the Popular Pharmacy program. In this way, the patient more easily adheres to the treatment of hypertension and reduces the risk of other fatal diseases.

Autores

Amanda de Castro Villela
Bárbara Stéphane de Macedo Guedes
Filipe Evangelista Silva Santos

Download